191 related articles for article (PubMed ID: 25286315)
1. Commentary: Omalizumab therapy for bullous pemphigoid by KK Yu, AB Crew, KAN Messingham, JA Fairley, DT Woodley. J Am Acad Dermatol 2014 Jun 20. pii: S0190-9622(14)01410-8. doi: 10.1016/j.jaad.2014.04.053. [Epub ahead of print].
Yancey KB
Dermatol Ther; 2015; 28(1):3. PubMed ID: 25286315
[No Abstract] [Full Text] [Related]
2. Omalizumab therapy for bullous pemphigoid.
Yu KK; Crew AB; Messingham KA; Fairley JA; Woodley DT
J Am Acad Dermatol; 2014 Sep; 71(3):468-74. PubMed ID: 24954907
[TBL] [Abstract][Full Text] [Related]
3. Successful management of severe infant bullous pemphigoid with omalizumab.
Dufour C; Souillet AL; Chaneliere C; Jouen F; Bodemer C; Jullien D; Cambazard F; Joly P; Reix P
Br J Dermatol; 2012 May; 166(5):1140-2. PubMed ID: 22098309
[No Abstract] [Full Text] [Related]
4. Successful treatment of bullous pemphigoid with omalizumab.
London VA; Kim GH; Fairley JA; Woodley DT
Arch Dermatol; 2012 Nov; 148(11):1241-3. PubMed ID: 23165827
[No Abstract] [Full Text] [Related]
5. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
Fairley JA; Baum CL; Brandt DS; Messingham KA
J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970
[No Abstract] [Full Text] [Related]
6. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200.
Yalcin AD; Genc GE; Celik B; Gumuslu S
Clin Lab; 2014; 60(3):523-4. PubMed ID: 24697134
[TBL] [Abstract][Full Text] [Related]
7. [Dermatological implications of omalizumab, an anti-IgE antibody].
Di Lucca-Chrisment J
Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
[TBL] [Abstract][Full Text] [Related]
8. Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Sabroe RA
Br J Dermatol; 2014 Jul; 171(1):13-5. PubMed ID: 25066289
[No Abstract] [Full Text] [Related]
9. [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].
Neumark M; Tal Y; Zlotogorski A; Molho-Pessach V
Harefuah; 2020 Jan; 159(1):29-30. PubMed ID: 31930804
[TBL] [Abstract][Full Text] [Related]
10. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema.
Azofra J; Díaz C; Antépara I; Jaúregui I; Soriano A; Ferrer M
Ann Allergy Asthma Immunol; 2015 May; 114(5):418-9.e1. PubMed ID: 25747788
[No Abstract] [Full Text] [Related]
11. Can omalizumab be effective in chronic eosinophilic pneumonia?
Domingo C; Pomares X
Chest; 2013 Jan; 143(1):274. PubMed ID: 23276861
[No Abstract] [Full Text] [Related]
12. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
Sastre I; Blanco J; Mata H; García F
J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
[No Abstract] [Full Text] [Related]
13. Biologics and the treatment of chronic rhinosinusitis.
Kern RC
J Allergy Clin Immunol; 2013 Jan; 131(1):117-8. PubMed ID: 23265697
[No Abstract] [Full Text] [Related]
14. Omalizumab for chronic urticaria.
Altman MC; Naimi DR
N Engl J Med; 2013 Jun; 368(26):2528-30. PubMed ID: 23802532
[No Abstract] [Full Text] [Related]
15. Omalizumab for chronic urticaria.
Benelli E; Ventura A
N Engl J Med; 2013 Jun; 368(26):2528. PubMed ID: 23802531
[No Abstract] [Full Text] [Related]
16. Omalizumab for chronic urticaria.
Wu K; Long H
N Engl J Med; 2013 Jun; 368(26):2527-8. PubMed ID: 23802530
[No Abstract] [Full Text] [Related]
17. Omalizumab for chronic urticaria.
Maurer M; Rosén K; Hsieh HJ
N Engl J Med; 2013 Jun; 368(26):2530. PubMed ID: 23802529
[No Abstract] [Full Text] [Related]
18. Anti-IgE therapy and severe atopic dermatitis: a pediatric perspective.
Lacombe Barrios J; Bégin P; Paradis L; Hatami A; Paradis J; Des Roches A
J Am Acad Dermatol; 2013 Nov; 69(5):832-834. PubMed ID: 24124824
[No Abstract] [Full Text] [Related]
19. Should clinicians use omalizumab for the treatment of nasal polyps?
Naclerio RM; Baroody FM; Pinto JM
J Allergy Clin Immunol; 2013 Jul; 132(1):247. PubMed ID: 23684073
[No Abstract] [Full Text] [Related]
20. JID VisualDx Quiz: January 2015.
Shabbir A; Kirsner RS
J Invest Dermatol; 2015 Jan; 135(1):1-2. PubMed ID: 25501381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
